145 related articles for article (PubMed ID: 15725865)
21. HPV for cervical cancer screening: is the era of the molecular pap smear upon us?
Stoler MH
J Histochem Cytochem; 2001 Sep; 49(9):1197-8. PubMed ID: 11511693
[TBL] [Abstract][Full Text] [Related]
22. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
23. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
24. Screening for cervical cancer.
Ronco G; Meijer CJ; Cuzick J; Giorgi-Rossi P; Peto J; Segnan N; Dillner J
Ann Intern Med; 2012 Apr; 156(8):604-5; author reply 605-6. PubMed ID: 22508738
[No Abstract] [Full Text] [Related]
25. Current status and future trends in cervical cancer screening.
Castle P; Dowdall M
Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
[No Abstract] [Full Text] [Related]
26. ACP Journal Club. Review: Self-collected samples are less accurate for HPV testing than clinician-collected samples.
Frank DA; Marrazzo J
Ann Intern Med; 2014 Aug; 161(4):JC11. PubMed ID: 25133378
[No Abstract] [Full Text] [Related]
27. Performance of vaginal self-sampling for human papillomavirus testing among women living with HIV in Botswana.
Elliott T; Kohler RE; Monare B; Moshashane N; Ramontshonyana K; Muthoga C; Wynn A; Howett R; Luckett R; Morroni C; Ramogola-Masire D
Int J STD AIDS; 2019 Oct; 30(12):1169-1176. PubMed ID: 31558129
[TBL] [Abstract][Full Text] [Related]
28. Acceptability of self-collected vaginal samples for HPV testing in an urban and rural population of Madagascar.
Broquet C; Triboullier D; Untiet S; Schafer S; Petignat P; Vassilakos P
Afr Health Sci; 2015 Sep; 15(3):755-61. PubMed ID: 26957962
[TBL] [Abstract][Full Text] [Related]
29. Barriers to HPV self-sampling and cytology among low-income indigenous women in rural areas of a middle-income setting: a qualitative study.
Allen-Leigh B; Uribe-Zúñiga P; León-Maldonado L; Brown BJ; Lörincz A; Salmeron J; Lazcano-Ponce E
BMC Cancer; 2017 Nov; 17(1):734. PubMed ID: 29121873
[TBL] [Abstract][Full Text] [Related]
30. [Self-sampling at home can prevent cervix cancer].
Sanner K; Wikström I; Lindell M; Strand A; Wilander E
Lakartidningen; 2009 Nov 11-17; 106(46):3075-7. PubMed ID: 19998610
[No Abstract] [Full Text] [Related]
31. Translational approaches to improving cervical screening.
Baldwin P; Laskey R; Coleman N
Nat Rev Cancer; 2003 Mar; 3(3):217-26. PubMed ID: 12612656
[TBL] [Abstract][Full Text] [Related]
32. Adding a test for human papillomavirus DNA to cervical-cancer screening.
Wright TC; Schiffman M
N Engl J Med; 2003 Feb; 348(6):489-90. PubMed ID: 12571255
[No Abstract] [Full Text] [Related]
33. When is it effective to offer self-sampling to non-attendees--response.
Rozemeijer K; de Kok IM; Naber SK; van Kemenade FJ; Penning C; van Rosmalen J; van Ballegooijen M
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1296. PubMed ID: 26240172
[No Abstract] [Full Text] [Related]
34. When is it effective to offer self-sampling to non-attendees--letter.
Castle PE
Cancer Epidemiol Biomarkers Prev; 2015 Aug; 24(8):1295. PubMed ID: 26240171
[No Abstract] [Full Text] [Related]
35. HPV screening offers greater protection against invasive cervical cancer than cytology, finds analysis.
Kmietowicz Z
BMJ; 2013 Nov; 347():f6624. PubMed ID: 24191217
[No Abstract] [Full Text] [Related]
36. Implementation of human papillomavirus testing in cervical screening without a concomitant decrease in participation rate.
Bulkmans NW; Bulk S; Ottevanger MS; Rozendaal L; Hellenberg SM; van Kemenade FJ; Snijders PJ; Boeke AJ; Meijer CJ
J Clin Pathol; 2006 Nov; 59(11):1218-20. PubMed ID: 16943223
[TBL] [Abstract][Full Text] [Related]
37. Use of cell block preparation for morphological, immunocytochemistry, and ploidy analysis in ThinPrep monolayer preparations.
Freitas C; Milanezi F; Dias AJ; Bento MJ; Schmitt FC
Diagn Cytopathol; 2001 Dec; 25(6):415-7. PubMed ID: 11747241
[No Abstract] [Full Text] [Related]
38. Colposcopy, cervical screening, and HPV. Preface.
Waxman AG
Obstet Gynecol Clin North Am; 2008 Dec; 35(4):xv-xvi. PubMed ID: 19061813
[No Abstract] [Full Text] [Related]
39. ACOG Practice Bulletin no. 109: Cervical cytology screening.
Obstet Gynecol; 2009 Dec; 114(6):1409-1420. PubMed ID: 20134296
[No Abstract] [Full Text] [Related]
40. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
